Value of ischemia-modified albumin for screening acute coronary syndrome

Jun MA,Fei WANG,Jia LIU,Xinwei QIAN,Yuanyuan LI,Xiaoye LU,Changqing ZHU,Nan FENG
DOI: https://doi.org/10.16150/j.1671-2870.2015.05.014
2015-01-01
Abstract:Objective: To investigate the value of ischemia-modified albumin (IMA) in rapid screening of acute coro-nary syndrome (ACS) at emergency department. Methods: A total of 105 cases attending our emergency center for chief complaint of acute chest pain were enrolled. All patients received rapid screening by 12 lead electrocardiograph (ECG), troponin I (TNI)and IMA. The cutoff value of IMA was calculated by the receiver operating characteristic (ROC) curve analysis, and was compared with the gold standard published by WHO. Results: Twenty-eight of the 105 cases were diag-nosed as ACS, the mean IMA value was (162.6±47.0) u/mL. The IMA value for non-ACS patients (77/105) was (139.0± 48.2) u/mL. The area under ROC curve was 0.632, cut-off value was 120.8 u/L. The sensitivity of IMA for diagnosing ACS was 75.00%, and the specificity was 44.16%, positive predictive value (PPV) was 82.93%. When combined with TNI, the sensitivity and specificity of IMA for diagnosing ACS were 92.86% and 32.47%, respectively. When combined with EKG, sensitivity and specificity of IMA for diagnosing ACS were 100%and 44.16%, respectively, while negative predictive value (NPV) was 100%. Conclusions:The value of IMA alone is not high enough for screening ACS. When combined with EKG or TNI, sensitivity for diagnosing ACS increases markedly. ACS could be excluded when the combined IMA and EKG showing negative results.
What problem does this paper attempt to address?